CD8A and neoplasm: (14) innovatively used machine learning algorithms to predict the expression levels of CD8 in tumor-infiltrating immune cells in NSCLC, leveraging PET/CT radiomics and clinical attributes, offering insights into the nuances of the tumor microenvironment.